Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome

Blood

Volumn 92, Issue 10, 1998, Pages 3546-3556

  Woolfrey, Ann E ^a   Gooley, Ted A ^b   Sievers, Eric L ^b   Milner, Laurie A ^b   Andrews, Robert G ^b   Walters, Mark ^b   Hoffmeister, Paul ^b   Hansen, John A ^b   Anasetti, Claudio ^b   Bryant, Eileen ^b   Appelbaum, Frederick R ^b   Sanders, Jean E ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CARDIOTOXICITY; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL TOXICITY; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; SKIN TOXICITY; WHOLE BODY RADIATION;

EID: 0032533259     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3546.422k37_3546_3556     Document Type: Article

References (60)

1. Nesbit ME Jr, Buckley J, Feig SA, Andersen J, Lampkin B, Bernstein ID, Kim TH, Piomelli S, Kersey JH, Coccia PF, O'Reilly RJ, August C, Thomas ED, Hammond GD: Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation of multi-agent chemotherapy. J Clin Oncol 12:127, 1994
2. madori S, Testi AM, Arico M, Comelli A, Giuliano M, Madon E, Masera G, Rondelli R, Zanesco L, Mandelli F: Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 11:1046, 1993
3. Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, Laver J, O'Reilly RJ: Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 317:1618, 1987
4. Anderson JE, Appelbaum FR, Fisher LD, Schoch G, Shulman H, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Doney K, Martin PJ, Sanders JE, Sullivan KM, Thomas ED, Witherspoon RP, Hansen JA, Storb R: Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 82:677, 1993
5. Johnson FL, Sanders JE, Ruggiero M, Chard RL Jr, Thomas ED: Bone marrow transplantation for the treatment of acute nonlymphoblastic leukemia in children aged less than 2 years. Blood 71:1277, 1988
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:626, 1985
7. Clift RA, Buckner CD, Appelbaum FR, Schoch G, Petersen FB, Bensinger WI, Sanders J, Sullivan KM, Storb R, Singer J, Hansen JA, Thomas ED: Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol 10:1723, 1992
8. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
9. Hansen JA, Mickelson EM, Choo SY, Petersdorf EW, Anasetti C, Martin PJ, Thomas ED: Clinical bone marrow transplantation: Donor selection and recipient monitoring, in Rose NR, De Macario EC, Fahey JL, Friedman H, Penn GM (eds): Manual of Clinical Laboratory Immunology, Washington, DC, American Society for Microbiology, 1992, p 850
10. Benyunes MC, Massumoto C, Higuchi CM, Buckner CD, Thompson JA, Petersen FB, Fefer A: lnterleukin-2 +/- lymphokine-activatecl killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 12:159, 1993
11. Robinson N, Sanders JE, Benyunes MC, Beach K, Lindgren C, Thompson JA, Appelbaum FR, Fefer A: Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia. Blood 87:1249, 1996
12. Dupont B, Yang SY: Histocompatibility, in Forman SJ, Blume KG. Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, p 22
13. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA: Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain, Immunogenetics 33:267, 1991
14. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensfeger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos B, O'Quigley J, Ramberg R, Sanders JE, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197, 1989
15. Thomas ED, Storb R: Technique for human marrow grafting. Blood 36:507, 1970
16. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T. Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
17. Storb R, Deeg HJ, Pepe M, Appelbaum FR, Anasetti C, Beatty P, Bensinger W, Berenson R, Buckner CD, Clift R, Doney K, Longton G, Hansen J, Hill R, Loughran T Jr, Martin P, Singer J, Sanders J, Stewart P, Sullivan K, Witherspoon R, Thomas ED: Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 73:1729, 1989
18. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ, Powderly WG, Silber JL, Horowitz H, Lichtin A, Wolff SN, Mangan KF, Silver SM, Weisdorf D, Ho WG, Gilbert G, Buell D: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845, 1992
19. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD: Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118:173, 1993
20. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA: Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study. Blood 88:4063, 1996
21. Durnam DM, Anders KR, Fisher L, O'Quigley JO, Bryant EM, Thomas ED: Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 74:2220, 1989
22. Blazar BR, Orr HT, Arthur DC, Kersey JH, Filipovich AH: Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 66:1436, 1985
23. Ugozzoli L, Yam P, Petz LD, Ferrara GB, Champlin RE, Forman SJ, Koyal D, Wallace RB: Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 77:1607, 1991
24. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, Thomas ED: Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562, 1988
25. Doney KC, Weiden PL, Storb R, Thomas ED: Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 11:1, 1981
26. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267, 1981
27. Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR: The measurement of performance in childhood cancer patients. Cancer 60:1651, 1987
28. Hill ID: The normal integral, in Griffiths P, Hill ID (eds): Applied Statistics Algorithms. Chichester, UK. Ellis Horwood, 1985, p 126
29. Wechsler D: Wechsler Preschool and Primary Intelligence Scales for Children, Revised. New York, NY, The Psychology Corp, 1989
30. Wechsler D: Intelligence Scale for Children, Revised. New York, NY, The Psychological Corp, 1974
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
32. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br J Haematol 83:602, 1993
33. Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, Barnard D, Benjamin D, DeSwarte J, Kalousek D, Shina D, Hammond GD, Lange BJ: Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Childrens Cancer Group pilot study. J Clin Oncol 11:1448, 1993
34. Wells RJ, Woods WG, Buekley JD, Odom LF, Benjamin D, Bernstein I, Betcher D, Feig S, Kim T, Ruymann F: Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Childrens Cancer Group study. J Clin Oncol 12:2367, 1994
35. Bostrom BB. Brunning RD, McGlave P, Ramsay N, Nesbit M Jr, Woods WG, Hurd D, Krivit W, Kim T, Goldman A, Kersey J: Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: Analysis of prognostic factors. Blood 65:1191, 1985
36. Stasi R, Del Poeta G, Masi M, Tribalto M, Venditti A, Papa G, Nicoletti B, Vernole P, Tedeschi B, Delaroche I, Mingarelli R, Dallapiccola B: Incidence of chromosome abnormalities and clincal significance of karyotype in de novo acute myeloid leukemia. Cancer Genet Cytogenet 67:28, 1993
37. Horowitz MM, Bortin MM: Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. Am J Pediatr Hematol Oncol 15:56, 1993
38. Lenarsky C, Weinberg K, Petersen J, Nolta J, Brooks J, Annett G, Kohn D, Parkman R: Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia. Bone Marrow Transplant 6:425, 1990
39. Mehta J, Powles R, Horton C, Milan S, Treleaven J, Tait D, Catovsky D: Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant 14:415, 1994
40. Schiller G, Feig SA, Territo M, Wolin M. Lill M, Belin T, Hunt L, Nimer S, Champlin R, Gajewski J: Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors. Br J Haematol 88:72, 1994
41. Clift RA, Buckner CD, Appelbaum FR, Bearman SI, Petersen FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill R, McDonald G, Martin P, Sanders J, Singer J, Stewart P, Sullivan KM, Witherspoon R, Storb R, Hansen J, Thomas ED: Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: A randomized trial of two irradiation regimens. Blood 76:1867, 1990
42. Woods WG, Kobrinsky N, Buckley J, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, DeSwarte J, Dusenbery K, Kalousek D, Arthur DC, Lange BJ: Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group. Blood 87:4979, 1996
43. Demirer T, Buckner CD, Appelbaum FR, Bensinger WI, Sanders J, Lambert K, Clift R, Fefer A, Storb R, Slattery JT: Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels. Bone Marrow Transplant 17:491, 1996
44. Petersen FB, Deeg HJ, Buckner CD, Appelbaum FR, Storb R, Clift RA, Sanders JE, Bensinger WI, Witherspoon RP, Sullivan KM, Doney K, Hansen JA: Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide - A jphase I trial. Int J Radiat Oncol Biol Physiol 23:1027, 1992
45. Slattery JT, Clift RA, Buckner CD, Radien J, Storer B, Bensinger WI, Soil E, Anasetti C, Bowden R, Bryant E, Chauncey T, Deeg HJ, Doney KC, Flowers M, Gooley T, Hansen JA, Martin PJ, McDonald GB, Nash R, Petersdorf EW, Sanders JE, Schoch G, Stewart P, Storb R, Sullivan KM, Thomas ED, Witherspoon RP, Appelbaum FR: Marrow transplantation for chronic myeloid leukemia: The influence of plasma busulfan levels on the outcome of transplantation. Blood 89:3055, 1997
46. 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 85:1122, 1995
47. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H-J, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
48. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW, Appelbaum FR, Buckner CD, Matthews D, Storb R, Sullivan KM, Hansen JA: Unrelated donor marrow transplantation in children. Blood 86:3247, 1995
49. Feig SA, Lampkin B, Nesbit ME, Woods WG, Versteeg CM, Buckley JD, Kim T, Hammond GD: Outcome of BMT during first complete remission of AML: A comparison of two sequential studies by the Childrens Cancer Group. Bone Marrow Transplant 12:65, 1993
50. Kolb H-J, Schattenberg A, Goldman J, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Gerrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H: Graft-versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041, 1995
51. Radien JP, Sanders JE, Buckner CD, Martin PJ, Peterson FB, Bensinger W, McDonald GB, Mori M, Schoch G, Hansen JA: Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 11:304, 1993
52. Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, Deeg HJ, Doney KC, Sullivan KM, Appelbaum FR, Storb R, Thomas ED: Growth and development following marrow transplantation for leukemia. Blood 68:1129, 1986
53. Sanders JE. and the Long-Term Follow-Up Team: Endocrine problems in children after bone marrow transplant for hematologic malignancies. Bone Marrow Transplant 8:2, 1991
54. Sanders J, Sullivan K, Witherspoon R, Doney K, Anasetti C, Beatty P, Petersen FB: Long term effects and quality of life in children and adults after marrow transplantation. Bone Marrow Transplant 4:27, 1989
55. Bozzola M, Giorgiani G. Locatelli F, Cisternino M, Gambarana D. Zecca M, Torcetta F, Severi F: Growth in children after bone marrow transplantation. Horm Res 39:122, 1993
56. Appelbaum FR, Barrall J, Storb R, Fisher LD, Schoch G, Ramberg RE, Shulman H, Anasetti C, Bearman SI, Beatty P, Bensinger WI, Buckner CD, Clift RA, Hansen JA. Martin P, Petersen FB, Sanders JE, Singer J, Stewart P, Sullivan KM. Witherspoon RP, Thomas ED: Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. Ann Intern Med 112:590, 1990
57. Guinan EC, Tarbell NJ, Tantravahi R, Weinstein HJ: Bone marrow transplantation for children with myelodysplastic syndromes. Blood 73:619, 1989
58. Longmore G, Guinan EC, Weinstein HJ, Gelber RD, Rappeport JM, Antin JH: Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia. J Clin Oncol 8:1707, 1990
59. Hasle H, Kemdrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Brock Jacobsen B: Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 10:1269, 1996
60. Passmore SJ, Hann IM, Stiller CA, Ramani P, Swansbury GJ, Gibbons B, Reeves BR, Chessells JM: Pediatric myelodysplasia: A study of 68 children and a new prognostic scoring system. Blood 85:1742, 1995